A Tmprss2-CreERT2 Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon.
Fusion between TMPRSS2 and ERG, placing ERG under the control of the TMPRSS2 promoter, is the most frequent genetic alteration in prostate cancer, present in 40-50% of cases. The fusion event is an early, if not initiating, event in prostate cancer, implicating the TMPRSS2-positive prostate epitheli...
Main Authors: | Dong Gao, Yu Zhan, Wei Di, Amanda R Moore, Jessica J Sher, Youxin Guan, Shangqian Wang, Zeda Zhang, Devan A Murphy, Charles L Sawyers, Ping Chi, Yu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0161084 |
Similar Items
-
stablishment and Characterization of Tie2-CreERT2 Transgenic Mice
by: Wei-Chi Huang, et al.
Published: (2007) -
Generation and Characterisation of a Pax8-CreERT2 Transgenic Line and a Slc22a6-CreERT2 Knock-In Line for Inducible and Specific Genetic Manipulation of Renal Tubular Epithelial Cells.
by: Judit Espana-Agusti, et al.
Published: (2016-01-01) -
In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control.
by: Anastasia Felker, et al.
Published: (2016-01-01) -
Effects of CreERT2, 4-OH Tamoxifen, and Gender on CFU-F Assays.
by: Sophie L McHaffie, et al.
Published: (2016-01-01) -
Split-CreERT2: temporal control of DNA recombination mediated by split-Cre protein fragment complementation.
by: Johannes Hirrlinger, et al.
Published: (2009-12-01)